Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective optionΙωάννα Λαζανά, Reuben Benjamin, Antonio Pagliuca et al.|Bone Marrow Transplantation|2022Cited by 25
A616 Response to Thalidomide in Patients with MM Following Disease Progression with PomalidomideTariq I. Mughal, Mary E. Smith, Matthew Streetly et al.|Clinical Lymphoma & Myeloma|2009Cited by 1
Retrospective analysis of the impact of kidney function on the outcomes of first autografts for de novo myeloma patients in the era of novel agentsLajos Flóró, Stephen Schey, Ιωάννα Λαζανά et al.|Clinical Lymphoma Myeloma & Leukemia|2015Cited by 1
Autologous stem cell transplantation with low-dose cyclophosphamide to improve mucosal healing in adults with refractory Crohn’s disease: the ASTIClite RCTJames O. Lindsay, John A. Snowden, Daniel Hind et al.|Efficacy and Mechanism Evaluation|2024Cited by 1
Development of Monoclonal Gammopathy of Undetermined Significance after Kidney TransplantJin-Lan Tan, Matthew Streetly, T. Dorling et al.|Clinical Lymphoma Myeloma & Leukemia|2015Cited by 0